![]()
|
|
||||||||
(Received for publication, March 18, 1996, and in revised form, May 17, 1996)
From the Department of Molecular Pharmacology and Biochemistry,
Merck Research Laboratories, Rahway, New Jersey 07065-0900
The neuropeptide Y family of peptides, which
includes neuropeptide Y (NPY), peptide YY (PYY), and pancreatic
polypeptide (PP), are found in the central and peripheral nervous
system and display a wide array of biological activities. These actions
are believed to be mediated through pharmacologically distinct G
protein-coupled receptors, and, to date, three members of the NPY
receptor family have been cloned. In this study we describe the cloning
and expression of a novel NPY receptor from mouse genomic DNA. This
receptor, designated NPY Y5, shares 60% amino acid identity to the
murine NPY Y1 receptor. The pharmacology of this novel receptor
resembles that of the NPY Y1 receptor and is distinct from that
described for the NPY Y2, Y3, and Y4 receptors. In situ
hybridization of mouse brain sections reveals expression of this
receptor within discrete regions of the hypothalamus including the
suprachiasmatic nucleus, anterior hypothalamus, bed nucleus stria
terminalis, and the ventromedial nucleus with no localization apparent
elsewhere in the brain.
Volume 271, Number 28,
Issue of July 12, 1996
pp. 16435-16438
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.
COMMUNICATION:
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
N. Merten, D. Lindner, N. Rabe, H. Rompler, K. Morl, T. Schoneberg, and A. G. Beck-Sickinger Receptor Subtype-specific Docking of Asp6.59 with C-terminal Arginine Residues in Y Receptor Ligands J. Biol. Chem., March 9, 2007; 282(10): 7543 - 7551. [Abstract] [Full Text] [PDF] |
||||
![]() |
E.-J. D. Lin, A. Sainsbury, N. J. Lee, D. Boey, M. Couzens, R. Enriquez, K. Slack, R. Bland, M. J. During, and H. Herzog Combined Deletion of Y1, Y2, and Y4 Receptors Prevents Hypothalamic Neuropeptide Y Overexpression-Induced Hyperinsulinemia despite Persistence of Hyperphagia and Obesity Endocrinology, November 1, 2006; 147(11): 5094 - 5101. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Misra, K. S. Murthy, H. Zhou, and J. R. Grider Coexpression of Y1, Y2, and Y4 Receptors in Smooth Muscle Coupled to Distinct Signaling Pathways J. Pharmacol. Exp. Ther., December 1, 2004; 311(3): 1154 - 1162. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Bonaventure, D. Nepomuceno, C. Mazur, B. Lord, D. A. Rudolph, J. A. Jablonowski, N. I. Carruthers, and T. W. Lovenberg Characterization of N-(1-Acetyl-2,3-dihydro-1H-indol-6-yl)-3-(3-cyano-phenyl)-N-[1-(2-cyclopentyl-ethyl)-piperidin-4yl]acrylamide (JNJ-5207787), a Small Molecule Antagonist of the Neuropeptide Y Y2 Receptor J. Pharmacol. Exp. Ther., March 1, 2004; 308(3): 1130 - 1137. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Simonneaux and C. Ribelayga Generation of the Melatonin Endocrine Message in Mammals: A Review of the Complex Regulation of Melatonin Synthesis by Norepinephrine, Peptides, and Other Pineal Transmitters Pharmacol. Rev., June 1, 2003; 55(2): 325 - 395. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Mashiko, A. Ishihara, H. Iwaasa, H. Sano, Z. Oda, J. Ito, M. Yumoto, M. Okawa, J. Suzuki, T. Fukuroda, et al. Characterization of Neuropeptide Y (NPY) Y5 Receptor-Mediated Obesity in Mice: Chronic Intracerebroventricular Infusion of D-Trp34NPY Endocrinology, May 1, 2003; 144(5): 1793 - 1801. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Berglund, P. A. Hipskind, and D. R. Gehlert Recent Developments in Our Understanding of the Physiological Role of PP-Fold Peptide Receptor Subtypes Experimental Biology and Medicine, March 1, 2003; 228(3): 217 - 244. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. C. Yannielli and M. E. Harrington The Neuropeptide Y Y5 Receptor Mediates the Blockade of "Photic-Like" NMDA-Induced Phase Shifts in the Golden Hamster J. Neurosci., July 15, 2001; 21(14): 5367 - 5373. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Goumain, T. Voisin, A.-M. Lorinet, R. Ducroc, A. Tsocas, C. Roze, P. Rouet-Benzineb, H. Herzog, A. Balasubramaniam, and M. Laburthe The Peptide YY-Preferring Receptor Mediating Inhibition of Small Intestinal Secretion Is a Peripheral Y2 Receptor: Pharmacological Evidence and Molecular Cloning Mol. Pharmacol., July 1, 2001; 60(1): 124 - 134. [Abstract] [Full Text] |
||||
![]() |
D. A. Schober, S. L. Gackenheimer, M. L. Heiman, and D. R. Gehlert Pharmacological Characterization of 125I-1229U91 Binding to Y1 and Y4 Neuropeptide Y/Peptide YY Receptors J. Pharmacol. Exp. Ther., April 1, 2000; 293(1): 275 - 280. [Abstract] [Full Text] |
||||
![]() |
A. Kanatani, S. Mashiko, N. Murai, N. Sugimoto, J. Ito, T. Fukuroda, T. Fukami, N. Morin, D. J. MacNeil, L. H. T. Van der Ploeg, et al. Role of the Y1 Receptor in the Regulation of Neuropeptide Y-Mediated Feeding: Comparison of Wild-Type, Y1 Receptor-Deficient, and Y5 Receptor-Deficient Mice Endocrinology, March 1, 2000; 141(3): 1011 - 1016. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Voisin, M. Goumain, A.-M. Lorinet, J.-J. Maoret, and M. Laburthe Functional and Molecular Properties of the Human Recombinant Y4 Receptor: Resistance to Agonist-Promoted Desensitization J. Pharmacol. Exp. Ther., February 1, 2000; 292(2): 638 - 646. [Abstract] [Full Text] |
||||
![]() |
A. J. Morris and C. C. Malbon Physiological Regulation of G Protein-Linked Signaling Physiol Rev, October 1, 1999; 79(4): 1373 - 1430. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Hallden, M. Hadi, H. T. Hong, and G. W. Aponte Y Receptor-mediated Induction of CD63 Transcripts, a Tetraspanin Determined To Be Necessary for Differentiation of the Intestinal Epithelial Cell Line, hBRIE 380i Cells J. Biol. Chem., September 24, 1999; 274(39): 27914 - 27924. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. D. Raposinho, P. Broqua, D. D. Pierroz, A. Hayward, Y. Dumont, R. Quirion, J.-L. Junien, and M. L. Aubert Evidence That the Inhibition of Luteinizing Hormone Secretion Exerted by Central Administration of Neuropeptide Y (NPY) in the Rat Is Predominantly Mediated by the NPY-Y5 Receptor Subtype Endocrinology, September 1, 1999; 140(9): 4046 - 4055. [Abstract] [Full Text] |
||||
![]() |
S. Iyengar, D. L. Li, and R. M. A. Simmons Characterization of Neuropeptide Y-Induced Feeding in Mice: Do Y1-Y6 Receptor Subtypes Mediate Feeding? J. Pharmacol. Exp. Ther., May 1, 1999; 289(2): 1031 - 1040. [Abstract] [Full Text] |
||||
![]() |
J. D. Winick and J. M. Friedman Microsatellite Marker Content Mapping of 12 Candidate Genes for Obesity: Assembly of Seven Obesity Screening Panels for Automated Genotyping Genome Res., September 1, 1998; 8(9): 985 - 994. [Abstract] [Full Text] |
||||
![]() |
Y. Dumont, A. Fournier, and R. Quirion Expression and Characterization of the Neuropeptide Y Y5 Receptor Subtype in the Rat Brain J. Neurosci., August 1, 1998; 18(15): 5565 - 5574. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Zukowska-Grojec, E. Karwatowska-Prokopczuk, W. Rose, J. Rone, S. Movafagh, H. Ji, Y. Yeh, W.-T. Chen, H. K. Kleinman, E. Grouzmann, et al. Neuropeptide Y : A Novel Angiogenic Factor From the Sympathetic Nerves and Endothelium Circ. Res., July 27, 1998; 83(2): 187 - 195. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Robidoux, L. Simoneau, S. St-Pierre, H. Ech-Chadli, and J. Lafond Human syncytiotrophoblast NPY receptors are located on BBM and activate PLC-to-PKC axis Am J Physiol Endocrinol Metab, March 1, 1998; 274(3): E502 - E509. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. T. Ault, J. M. Radeff, and L. L. Werling Modulation of [3H]Dopamine Release from Rat Nucleus Accumbens by Neuropeptide Y May Involve a Sigma1-like Receptor J. Pharmacol. Exp. Ther., February 1, 1998; 284(2): 553 - 560. [Abstract] [Full Text] |
||||
![]() |
D. P. D. Woldbye, K. Klemp, and T. M. Madsen Neuropeptide Y Attenuates Naloxone-Precipitated Morphine Withdrawal via Y5-like Receptors J. Pharmacol. Exp. Ther., February 1, 1998; 284(2): 633 - 636. [Abstract] [Full Text] |
||||
![]() |
C. Schwarzer, N. Kofler, and G. Sperk Up-Regulation of Neuropeptide Y-Y2 Receptors in an Animal Model of Temporal Lobe Epilepsy Mol. Pharmacol., January 1, 1998; 53(1): 6 - 13. [Abstract] [Full Text] |
||||
![]() |
M. Jackerott and L.-I. Larsson Immunocytochemical Localization of the NPY/PYY Y1 Receptor in Enteric Neurons, Endothelial Cells, and Endocrine-like Cells of the Rat Intestinal Tract J. Histochem. Cytochem., December 1, 1997; 45(12): 1643 - 1650. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Jackerott and L.-I. Larsson Immunocytochemical Localization of the NPY/PYY Y1 Receptor in the Developing Pancreas Endocrinology, November 1, 1997; 138(11): 5013 - 5018. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Small, D. G. A. Morgan, K. Meeran, M. M. Heath, I. Gunn, C. M. B. Edwards, J. Gardiner, G. M. Taylor, J. D. Hurley, M. Rossi, et al. Peptide analogue studies of the hypothalamic neuropeptide Y receptor mediating pituitary adrenocorticotrophic hormone release PNAS, October 14, 1997; 94(21): 11686 - 11691. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Leupen, L. M. Besecke, and J. E. Levine Neuropeptide Y Y1-Receptor Stimulation Is Required for Physiological Amplification of Preovulatory Luteinizing Hormone Surges Endocrinology, July 1, 1997; 138(7): 2735 - 2739. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Rhim, G. A. Kinney, P. J. Emmerson, and R. J. Miller Regulation of Neurotransmission in the Arcuate Nucleus of the Rat by Different Neuropeptide Y Receptors J. Neurosci., May 1, 1997; 17(9): 2980 - 2989. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. M. Rose, J. S. Lynch, S. T. Frazier, S. M. Fisher, W. Chung, P. Battaglino, Z. Fathi, R. Leibel, and P. Fernandes Molecular Genetic Analysis of a Human Neuropeptide Y Receptor. THE HUMAN HOMOLOG OF THE MURINE "Y5" RECEPTOR MAY BE A PSEUDOGENE J. Biol. Chem., February 7, 1997; 272(6): 3622 - 3627. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. O'Shea, D. G. A. Morgan, K. Meeran, C. M. B. Edwards, M. D. Turton, S. J. Choi, M. M. Heath, I. Gunn, G. M. Taylor, J. K. Howard, et al. Neuropeptide Y Induced Feeding in the Rat Is Mediated by a Novel Receptor Endocrinology, January 1, 1997; 138(1): 196 - 202. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Chen and A. N. van den Pol Multiple NPY Receptors Coexist in Pre- and Postsynaptic Sites: Inhibition of GABA Release in Isolated Self-Innervating SCN Neurons J. Neurosci., December 1, 1996; 16(23): 7711 - 7724. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Matsumoto, T. Nomura, K. Momose, Y. Ikeda, Y. Kondou, H. Akiho, J. Togami, Y. Kimura, M. Okada, and T. Yamaguchi Inactivation of a Novel Neuropeptide Y/Peptide YY Receptor Gene in Primate Species J. Biol. Chem., November 1, 1996; 271(44): 27217 - 27220. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. N. van den Pol, K. Obrietan, G. Chen, and A. B. Belousov Neuropeptide Y-Mediated Long-Term Depression of Excitatory Activity in Suprachiasmatic Nucleus Neurons J. Neurosci., September 15, 1996; 16(18): 5883 - 5895. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |